113 related articles for article (PubMed ID: 7671451)
1. Cromakalim suppresses hypertonic saline-induced renal vasoconstriction in anaesthetized dogs.
Ogasawara A; Hirano T; Hisa H; Satoh S
Clin Exp Pharmacol Physiol; 1995 Apr; 22(4):311-3. PubMed ID: 7671451
[TBL] [Abstract][Full Text] [Related]
2. Effects of cromakalim on renal hemodynamics and function in dogs: comparison with nicardipine.
Tamaki T; Hasui K; Shoji T; Fukui K; Iwao H; Abe Y
J Cardiovasc Pharmacol; 1991 Feb; 17(2):305-9. PubMed ID: 1709236
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary vascular and renal effects of cromakalim in anaesthetized dogs.
Hicks PE; Martin D; Dumez D; Zazzi-Sudriez E; Armstrong JM
Pflugers Arch; 1989; 414 Suppl 1():S192-3. PubMed ID: 2780259
[TBL] [Abstract][Full Text] [Related]
4. Effects of nifedipine and TMB-8 on renal vasoconstriction induced by hypertonic saline in dogs.
Ogasawara A; Hisa H; Satoh S
Eur J Pharmacol; 1993 Oct; 243(1):103-6. PubMed ID: 8253119
[TBL] [Abstract][Full Text] [Related]
5. Effects of BRL 34915 (cromakalim) on renal hemodynamics and function in anesthetized dogs.
Hayashi K; Matsumura Y; Yoshida Y; Ohyama T; Hisaki K; Suzuki Y; Morimoto S
J Pharmacol Exp Ther; 1990 Mar; 252(3):1240-6. PubMed ID: 2108239
[TBL] [Abstract][Full Text] [Related]
6. K+ channel-opening action contributes to the preventive effects of nicorandil on U46619-induced vasoconstriction of canine large coronary arteries in vivo.
Kamijo T; Iwai T; Haruta K; Takeda K
Arch Int Pharmacodyn Ther; 1996; 331(3):273-84. PubMed ID: 9124999
[TBL] [Abstract][Full Text] [Related]
7. Effect of BRL 38227 on the adrenergic regulation of the kidney vasculature of the rat.
Johns EJ
Eur J Pharmacol; 1993 Jan; 230(1):47-51. PubMed ID: 8428603
[TBL] [Abstract][Full Text] [Related]
8. Atrial natriuretic factor inhibits hypertonic saline-mediated decreases in renal hemodynamics.
Loftus JP; Redfield MM; Burnett JC
Kidney Int; 1990 Aug; 38(2):227-31. PubMed ID: 2144881
[TBL] [Abstract][Full Text] [Related]
9. Venoconstriction to endothelin-1 in humans: role of calcium and potassium channels.
Haynes WG; Webb DJ
Am J Physiol; 1993 Nov; 265(5 Pt 2):H1676-81. PubMed ID: 8238579
[TBL] [Abstract][Full Text] [Related]
10. Effects of hyperosmotic mannitol infusion on hemodynamics of dog kidney.
Behnia R; Koushanpour E; Brunner EA
Anesth Analg; 1996 May; 82(5):902-8. PubMed ID: 8610896
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the vasodilatation by the K+ channel openers: cromakalim and pinacidil.
Rhim BY; Lee WS; Hong KW
Jpn J Pharmacol; 1992; 58 Suppl 2():335P. PubMed ID: 1507584
[No Abstract] [Full Text] [Related]
12. Intrarenal hypertonic saline infusions in dogs with thoracic caval constriction.
Heidemann HT; Jackson EK; Gerkens JF; Branch RA
Kidney Int; 1987 Oct; 32(4):488-92. PubMed ID: 3430950
[TBL] [Abstract][Full Text] [Related]
13. Antihypertensive and haemodynamic properties of the potassium channel activating (-) enantiomer of cromakalim in animal models.
Clapham JC; Hamilton TC; Longman SD; Buckingham RE; Campbell CA; Ilsley GL; Gout B
Arzneimittelforschung; 1991 Apr; 41(4):385-91. PubMed ID: 1907150
[TBL] [Abstract][Full Text] [Related]
14. K+ channel opening mediates the vasorelaxant effects of nicorandil in the intact vascular system.
Cavero I; Pratz J; Mondot S
Z Kardiol; 1991; 80 Suppl 7():35-41. PubMed ID: 1838848
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of renal vasoconstriction induced by intrarenal hypertonic saline by the nonxanthine adenosine antagonist CGS 15943A.
Callis JT; Kuan CJ; Branch KR; Abels BC; Sabra R; Jackson EK; Branch RA
J Pharmacol Exp Ther; 1989 Mar; 248(3):1123-9. PubMed ID: 2703965
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular effects of KRN2391 in anesthetized dogs: a comparison with cromakalim and nitroglycerin.
Kaneta S; Yokoyama T; Izumi H; Izawa T; Ogawa N
Arch Int Pharmacodyn Ther; 1994; 327(2):184-93. PubMed ID: 7979827
[TBL] [Abstract][Full Text] [Related]
17. Comparison of effects of cromakalim and pinacidil on mechanical activity and 86Rb efflux in dog coronary arteries.
Masuzawa K; Asano M; Matsuda T; Imaizumi Y; Watanabe M
J Pharmacol Exp Ther; 1990 May; 253(2):586-93. PubMed ID: 2160002
[TBL] [Abstract][Full Text] [Related]
18. Effects of brain natriuretic peptide on renin secretion in normal and hypertonic saline-infused kidney.
Akabane S; Matsushima Y; Matsuo H; Kawamura M; Imanishi M; Omae T
Eur J Pharmacol; 1991 Jun; 198(2-3):143-8. PubMed ID: 1864303
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary and systemic haemodynamic effects of cromakalim in conditions of normoxia and hypoxia in dogs.
Martin DJ; Gellotte M; Armstrong JM; Hicks PE
J Auton Pharmacol; 1990 Oct; 10(5):261-72. PubMed ID: 2084109
[TBL] [Abstract][Full Text] [Related]
20. Dissimilarity in the mechanisms of action of KRN2391, nicorandil and cromakalim in canine renal artery.
Kasai H; Fukata Y; Harada K; Fukushima H; Ogawa N
J Pharm Pharmacol; 1993 Mar; 45(3):222-4. PubMed ID: 8097782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
